|
GPN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.73840000003722E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.3188999999666E-06 |
| Normal-vs-Stage2 |
1.035170E-03 |
| Normal-vs-Stage3 |
1.436500E-02 |
| Normal-vs-Stage4 |
5.298000E-03 |
| Stage1-vs-Stage2 |
9.558200E-01 |
| Stage1-vs-Stage3 |
4.254800E-01 |
| Stage1-vs-Stage4 |
9.686000E-01 |
| Stage2-vs-Stage3 |
5.416200E-01 |
| Stage2-vs-Stage4 |
9.297000E-01 |
| Stage3-vs-Stage4 |
5.793600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83490999999814E-05 |
| Normal-vs-AfricanAmerican |
3.028800E-04 |
| Normal-vs-Asian |
1.942210E-02 |
| Caucasian-vs-AfricanAmerican |
9.450800E-01 |
| Caucasian-vs-Asian |
7.485800E-01 |
| AfricanAmerican-vs-Asian |
7.377400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84150000004379E-06 |
| Normal-vs-Female |
2.041500E-03 |
| Male-vs-Female |
1.557160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.84519999999666E-05 |
| Normal-vs-Extreme_Weight |
2.96820000000864E-06 |
| Normal-vs-Obese |
1.837600E-03 |
| Normal-vs-Extreme_Obese |
4.30439999999921E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.701200E-01 |
| Normal_Weight-vs-Obese |
1.276610E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.997800E-01 |
| Extreme_Weight-vs-Obese |
1.866550E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.984370E-01 |
| Obese-vs-Extreme_Obese |
6.365900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.431600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.17910000000132E-05 |
| Normal-vs-Age(61-80Yrs) |
1.58521999999994E-05 |
| Normal-vs-Age(81-100Yrs) |
2.420400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.112000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.354000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.555600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.422200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.482600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.230800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.90300000000055E-06 |
| Normal-VS-Type2 PRCC |
4.433400E-04 |
| Normal-VS-KIRP CIMP |
7.291500E-02 |
| Normal-VS-Unclassified PRCC |
3.649700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.430000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.328600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.688000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.901600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.176600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.585400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.17950000000111E-05 |
| Normal-vs-N1 |
8.102000E-02 |
| Normal-vs-N2 |
3.218400E-02 |
| N0-vs-N1 |
1.596830E-01 |
| N0-vs-N2 |
9.985000E-01 |
| N1-vs-N2 |
5.204200E-01 |
|
|
